自分泌运动因子-溶血磷脂酸信号通路成为预防肝癌的一个治疗靶点。
The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer.
作者信息
Erstad Derek J, Tager Andrew M, Hoshida Yujin, Fuchs Bryan C
机构信息
Division of Surgical Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.
Center for Immunology and Inflammatory Diseases, Fibrosis Research Center, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
出版信息
Mol Cell Oncol. 2017 Mar 31;4(3):e1311827. doi: 10.1080/23723556.2017.1311827. eCollection 2017.
Abstract
Using transcriptome meta-analysis, we recently identified the autotaxin (ATX)-lysophosphatidic acid (LPA) pathway as a regulator of hepatocellular carcinoma (HCC) risk in human cirrhosis patients. Pharmacological targeting of this pathway reduced fibrosis progression and HCC development in animals, identifying ATX-LPA signaling as a novel chemoprevention strategy for cirrhosis and HCC.
摘要
利用转录组荟萃分析，我们最近确定自分泌运动因子（ATX）-溶血磷脂酸（LPA）通路是人类肝硬化患者肝细胞癌（HCC）风险的一个调节因子。对该通路进行药物靶向治疗可减少动物体内的纤维化进展和HCC发展，这表明ATX-LPA信号传导是一种针对肝硬化和HCC的新型化学预防策略。
相似文献
1
The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer.自分泌运动因子-溶血磷脂酸信号通路成为预防肝癌的一个治疗靶点。
Mol Cell Oncol. 2017 Mar 31;4(3):e1311827. doi: 10.1080/23723556.2017.1311827. eCollection 2017.
2
Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer.肝癌中溶血磷脂酸代谢与信号传导的失调
Cancers (Basel). 2019 Oct 23;11(11):1626. doi: 10.3390/cancers11111626.
3
Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.自分泌酶-溶血磷脂酸受体信号调节丙型肝炎病毒复制。
J Hepatol. 2017 May;66(5):919-929. doi: 10.1016/j.jhep.2017.01.009. Epub 2017 Jan 23.
4
Implications of the lysophosphatidic acid signaling axis in liver cancer.溶血磷脂酸信号轴在肝癌中的意义。
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):277-282. doi: 10.1016/j.bbcan.2017.06.002. Epub 2017 Jun 4.
5
Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease.酒精使用障碍合并肝病的戒酒患者中溶血磷脂酸和自分泌运动因子的血浆浓度
Biomedicines. 2021 Sep 13;9(9):1207. doi: 10.3390/biomedicines9091207.
6
Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis.在肝纤维化晚期的临床前模型中，对一种选择性、口服生物利用度的自分泌酶抑制剂的特性进行了表征。
Br J Pharmacol. 2018 Feb;175(4):693-707. doi: 10.1111/bph.14118. Epub 2018 Jan 17.
7
Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.自分泌运动因子/自分泌运动因子-溶血磷脂酸轴在肝癌发生发展中的作用
Front Oncol. 2022 Jun 13;12:922945. doi: 10.3389/fonc.2022.922945. eCollection 2022.
8
Hepatocyte autotaxin expression promotes liver fibrosis and cancer.肝细胞自分泌运动因子表达促进肝纤维化和肝癌。
Hepatology. 2017 Apr;65(4):1369-1383. doi: 10.1002/hep.28973. Epub 2017 Feb 7.
9
Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels.肝细胞癌中较高的LPA2和LPA6 mRNA水平与较差的分化、微血管侵犯以及更高的血清自分泌运动因子水平导致的更早复发相关。
PLoS One. 2016 Sep 1;11(9):e0161825. doi: 10.1371/journal.pone.0161825. eCollection 2016.
10
Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis.设计抗自分泌酶-LPAR GPCR 轴的双重抑制剂。
Molecules. 2022 Aug 26;27(17):5487. doi: 10.3390/molecules27175487.
引用本文的文献
1
Generation of New Knock-Out Mouse Strains of ..的新型基因敲除小鼠品系的产生
Int J Mol Sci. 2025 Mar 20;26(6):2811. doi: 10.3390/ijms26062811.
2
A novel strategy for sorafenib-resistant hepatocellular carcinoma: autotaxin Inhibition by PF-8380.索拉非尼耐药肝细胞癌的一种新策略：PF-8380抑制自分泌运动因子
J Cancer Res Clin Oncol. 2025 Mar 13;151(3):110. doi: 10.1007/s00432-025-06156-3.
3
Hypoxia Increases ATX Expression by Histone Crotonylation in a HIF-2α-Dependent Manner.缺氧通过组蛋白巴豆酰化依赖 HIF-2α 增加 ATX 的表达。
Int J Mol Sci. 2023 Apr 11;24(8):7031. doi: 10.3390/ijms24087031.
4
Berberine inhibits carcinogenesis through antagonizing the ATX-LPA-LPAR2-p38-leptin axis in a mouse hepatoma model.在小鼠肝癌模型中，小檗碱通过拮抗自噬相关蛋白6-溶血磷脂酸-溶血磷脂酸受体2-p38-瘦素轴抑制肿瘤发生。
Mol Ther Oncolytics. 2022 Aug 5;26:372-386. doi: 10.1016/j.omto.2022.08.001. eCollection 2022 Sep 15.
5
Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis.设计抗自分泌酶-LPAR GPCR 轴的双重抑制剂。
Molecules. 2022 Aug 26;27(17):5487. doi: 10.3390/molecules27175487.
6
Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.自分泌运动因子/自分泌运动因子-溶血磷脂酸轴在肝癌发生发展中的作用
Front Oncol. 2022 Jun 13;12:922945. doi: 10.3389/fonc.2022.922945. eCollection 2022.
7
Influence of the autotaxin-lysophosphatidic acid axis on cellular function and cytokine expression in different breast cancer cell lines.自分泌酶-溶血磷脂酸轴对不同乳腺癌细胞系细胞功能和细胞因子表达的影响。
Sci Rep. 2022 Apr 1;12(1):5565. doi: 10.1038/s41598-022-09565-3.
8
Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.脂肪组织和脂肪因子与肥胖相关性肝癌发展的相关性。
Int J Mol Sci. 2021 Feb 22;22(4):2163. doi: 10.3390/ijms22042163.
9
Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axis.FOXF1 表达缺失通过 ATX/LPA/LPA1 信号轴促进人肺固有间充质基质细胞迁移。
Sci Rep. 2020 Dec 4;10(1):21231. doi: 10.1038/s41598-020-77601-1.
10
Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer.脂肪组织衍生自分泌酶、溶血磷脂酸信号转导与炎症在乳腺癌的进展和治疗中的作用。
Int J Mol Sci. 2020 Aug 18;21(16):5938. doi: 10.3390/ijms21165938.
本文引用的文献
1
Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials.肝细胞癌中的免疫检查点抑制：基础与正在进行的临床试验
Oncology. 2017;92 Suppl 1:50-62. doi: 10.1159/000451016. Epub 2017 Feb 2.
2
Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.自分泌酶-溶血磷脂酸受体信号调节丙型肝炎病毒复制。
J Hepatol. 2017 May;66(5):919-929. doi: 10.1016/j.jhep.2017.01.009. Epub 2017 Jan 23.
3
Hepatocyte autotaxin expression promotes liver fibrosis and cancer.肝细胞自分泌运动因子表达促进肝纤维化和肝癌。
Hepatology. 2017 Apr;65(4):1369-1383. doi: 10.1002/hep.28973. Epub 2017 Feb 7.
4
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.通过器官转录组分析和溶血磷脂酸途径抑制实现肝硬化中分子水平的肝癌预防
Cancer Cell. 2016 Dec 12;30(6):879-890. doi: 10.1016/j.ccell.2016.11.004.
5
Selective Inhibition of Autotaxin Is Efficacious in Mouse Models of Liver Fibrosis.自分泌运动因子的选择性抑制在肝纤维化小鼠模型中有效。
J Pharmacol Exp Ther. 2017 Jan;360(1):1-13. doi: 10.1124/jpet.116.237156. Epub 2016 Oct 17.
6
Lysophosphatidic acid as a lipid mediator with multiple biological actions.溶血磷脂酸作为一种具有多种生物学作用的脂质介质。
J Biochem. 2015 Feb;157(2):81-9. doi: 10.1093/jb/mvu077. Epub 2014 Dec 11.
7
Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?美国肝细胞癌的流行病学：我们目前的状况如何？我们将何去何从？
Hepatology. 2014 Nov;60(5):1767-75. doi: 10.1002/hep.27222. Epub 2014 Aug 25.
8
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.表皮生长因子受体抑制可减轻肝纤维化和肝癌的发展。
Hepatology. 2014 Apr;59(4):1577-90. doi: 10.1002/hep.26898. Epub 2014 Feb 28.
9
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.肝细胞癌的防治：潜在靶点、实验模型与临床挑战。
Curr Cancer Drug Targets. 2012 Nov 1;12(9):1129-59.
10
Autotaxin as a novel serum marker of liver fibrosis.Autotaxin 作为一种新型血清肝纤维化标志物。
Clin Chim Acta. 2011 Jun 11;412(13-14):1201-6. doi: 10.1016/j.cca.2011.03.014. Epub 2011 Mar 17.
Zotero 插件